Logo.png
Palisade Bio Launches New Corporate Branding and Reiterates Commitment to Advancing Next-Generation Precision Therapies
September 16, 2024 08:00 ET | Palisade Bio, Inc.
– Company remains committed to its mission to become a leader in developing differentiated product candidates targeting immune, inflammatory and fibrotic diseases – Successful completion of...
Deep Lens
New Platform Provides Patients Options for Cancer Screenings, Trials
August 20, 2020 09:00 ET | Franciscan Health
INDIANAPOLIS and COLUMBUS, Ohio, Aug. 20, 2020 (GLOBE NEWSWIRE) -- In the midst of the COVID-19 pandemic, many medical institutions around the country have suspended or ended clinical trials. But...